![Careers in Discovery](https://pbcdn1.podbean.com/imglogo/image-logo/18676005/1478977-1674819143110-a9f40d319527c.jpg)
1K
Downloads
134
Episodes
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
Episodes
![Ben Cross, PhoreMost](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Ben_Cross_1__rb73vm_300x300.png)
2 days ago
Ben Cross, PhoreMost
2 days ago
2 days ago
We first interviewed Ben Cross five years ago, when he was the Head of Functional Genomics at Horizon Discovery, and we're delighted to welcome him back to the podcast as CTO of PhoreMost, an innovative target discovery company focused on drugging the undruggable.
Ben caught us up on what he's learned over the last five years, including why failing fast isn't a viable strategy in drug discovery, and introduced us to PhoreMost's brand new molecular glue platform, GlueSeeker.
![Shane Hegarty, Axonis Therapeutics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Shane_Hegarty_qwjr32_300x300.png)
Wednesday Jun 19, 2024
Shane Hegarty, Axonis Therapeutics
Wednesday Jun 19, 2024
Wednesday Jun 19, 2024
Shane Hegarty is the Chief Scientific Officer of Axonis Therapeutics, a Boston-based Biotech targeting KCC2 to revive neurons and treat people suffering from neurological disorders.
Shane shared with us the story of his transition from academic to Biotech entrepreneur, why communication, persistence, collaboration and focus are critical skills for success, his amazing track record of securing grant funding, and much more.
![Maude Tessier, Seismic Therapeutic](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/Copy_of_CiD_-_Vern_de_Biasi_h5m94g_300x300.png)
Wednesday Jun 12, 2024
Maude Tessier, Seismic Therapeutic
Wednesday Jun 12, 2024
Wednesday Jun 12, 2024
Maude Tessier is the Chief Business Officer at Seismic Therapeutic, the machine learning immunology company building a discovery platform centred on parallel drug development.
Maude joined us on Careers in Discovery to talk about the impact of machine learning on drug development, taking control of her career by literally knocking on doors, balancing humility and confidence, and much more.
![Vern de Biasi, BenevolentAI](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Vern_de_Biasi_5j4gd7_300x300.png)
Wednesday Jun 05, 2024
Vern de Biasi, BenevolentAI
Wednesday Jun 05, 2024
Wednesday Jun 05, 2024
Vern de Biasi is VP of Business Development at BenevolentAI, one of the world's leaders in the application of cutting edge technology to drug discovery.
Vern's career has seen him travel the world, from the UK to Italy, China and the US, and he shared with us the key lessons he's learned along the way.
![Jordan Lane, Ignota Labs](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Jordan_Lane_r4dw6j_300x300.png)
Wednesday May 29, 2024
Jordan Lane, Ignota Labs
Wednesday May 29, 2024
Wednesday May 29, 2024
Jordan Lane is the Chief Scientific Officer of Ignota Labs, a company leveraging AI to rescue failed drug programmes.
Jordan joined us to talk about building conviction, seeking feedback & maintaining networks, the huge opportunity lying in failed research, and why risk is relative in your career.
![Bill Eldridge, Isogenica](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/3f97072ca82cd77794cccc932fe74c09_300x300.jpg)
Wednesday Apr 03, 2024
Bill Eldridge, Isogenica
Wednesday Apr 03, 2024
Wednesday Apr 03, 2024
Bill Eldridge is an experienced scientific and commercial leader, one of the founding team members of the VHH antibody company Isogenica, and now their CEO.
Bill joined us to talk about his career, the huge potential that still exists within antibody discovery and the magic of seeing a 96 well ELISA plate turn blue after months of failure!
Enjoy...
![Namir Hassan, Zelluna Immunotherapy](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/eb3ac42a0ac8ca38a6e76744259be768_300x300.jpg)
Wednesday Mar 13, 2024
Namir Hassan, Zelluna Immunotherapy
Wednesday Mar 13, 2024
Wednesday Mar 13, 2024
Namir Hassan is the CEO of Zelluna Immunotherapy, a cancer cell therapy company harnessing natural immunity to treat solid tumours.
Namir joined us on Careers in Discovery to talk about when precision medicine gets too precise, the importance of servant leadership and trusting the journey in your career.
Enjoy!
![Jane Dancer](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/8e9ef842d93c6601bfc6652292a123b0_300x300.jpg)
Wednesday Feb 28, 2024
Jane Dancer
Wednesday Feb 28, 2024
Wednesday Feb 28, 2024
Now a Non-Executive at a range of leading Biotech companies including Spirea, PharmEnable, Macomics, NanoSyrinx and Elasmogen, Jane Dancer has built a highly successful career in Business Development in the sector.
Jane joined us to discuss that career, how she created a portfolio of NED positions, the real value of an MBA and whether you really need a PhD.
Enjoy!
![Image](https://pbcdn1.podbean.com/fs1/user-site-dist/assets/customize-component4.png)
Your Title
This is the description area. You can write an introduction or add anything you want to tell your audience. This can help potential listeners better understand and become interested in your podcast. Think about what will motivate them to hit the play button. What is your podcast about? What makes it unique? This is your chance to introduce your podcast and grab their attention.